Keywords
epidemiology
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the mortality rate from neoplasms in the population of the municipality of Nova Iguaçu from 2000 to 2019. Methods: Cohort study, analyzing data on deaths from neoplasms specified in the ICD 10 subchapters (C00 to C97) of the Mortality Information System, including individuals aged ≥ 20 years, separated by gender, year, type of neoplasm, education, ethnicity, marital status and age group. Results: 14,875 deaths from neoplasms were recorded (50.3% female), an average of 371.8 deaths/year. The mortality rate grew 68% from 2002 (77.8/100,000 inhab.) to 2018 (113.5/100,000 inhab.) with proportional mortality ranging from 9% to 16%. The digestive system accumulated more deaths, with a predominant age group between 60-79 years. The subchapters C00-C14, C15-C26, C30-C39, C40-C41, C43-C44, C50, C51-C58, C60-C63, C64-C68, C81- C96 showed difference in deaths between genders (p≤0.05). Conclusion: The mortality rate from neoplasms almost doubled in 20 years, being higher in females, with a predominance in the age group between 60 and 79 years in both sexes. The highest number of deaths from neoplasms was related to the digestive system, followed by pulmonary and intrathoracic organs, 1/3 of deaths in females were related to the mammary system and reproductive organ.
References
AIZER AA, et al. Marital status and survival in patients with cancer. Journal of Clinical Oncology, 2013; 31(31):3869–76.
BRASIL. Ministério da Saúde. Ficha técnica Municipal do Município de Nova Iguaçu. Governo do Rio de Janeiro. 2016. Disponível em: https://www.saude.rj.gov.br/comum/code/MostrarArquivo.php?C=Mzk4MA%2C%2C. Acessado em: fevereiro de 2023.
BRAY F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer Journal of Clinicians, 2018; 68(6):394–424.
COUZIN FJ. Breakthrough of the year 2013. Cancer immunotherapy. Science, 2013; 342(6165):1432–3.
CROUSE DL, et al. Postmenopausal Breast Cancer Is Associated with Exposure to Traffic-Related Air Pollution in Montreal, Canada: A Case–Control Study. Environmental Health Perspectives, 2010; 118(11):1578–83.
DA SILVA PA e RIUL SS. Câncer de mama: fatores de risco e detecção precoce. Revista. Brasileira de Enfermagem, 2011; 64(6):1016–21.
FAJERSZTAJN L, et al. Air pollution: a potentially modifiable risk factor for lung cancer. Nature Review Cancer, 2013; 13(9):674–8.
IBGE. Instituto Brasileiro de Geografia e Estatística. Cidades e Estados - Nova Iguaçu (RJ), 2021. Nova Iguaçu. Disponível em: https://ibge.gov.br/cidades-e-estados/rj/nova-iguacu.html. Acessado em: 20 de janeiro 2023.
INCA. Instituto Nacional de Câncer. ABC do câncer: abordagens básicas para o controle do câncer [internet]. 6. ed. rev. atual. – Rio de Janeiro: INCA. 2020. Disponível em:https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document/livro_abc_6ed_0.pdf. Acessado em: 22 de fevereiro 2023.
INCA. Instituto Nacional de Câncer. Estimativa 2020: incidência de câncer no Brasil. Ministério da Saúde. Rio de Janeiro. 2019. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Acessado em: 22 de fevereiro de 2023.
INCA. Instituto Nacional de Câncer. Estimativa 2014: Incidência de câncer no Brasil. Coordenação de Prevenção e Vigilância. Ministério da Saúde. Rio de Janeiro. 2014. Disponível em: https://www.inca.gov.br/bvscontrolecancer/publicacoes/Estimativa_2014.pdf. Acessado em: 18 de abril 2023.
MENDES JDV. Vista do Mortalidade regional por câncer no estado de São Paulo – comparação entre triênios 2006/2008 e 2016/2018. Boletim epidemiológico Paulista, 2020; 17(200):3-36.
MIGOWSKI A, et al. Atenção Oncológica e os 30 Anos do Sistema Único de Saúde. Revista Brasileira de Cancerologia, 2018; 64(2): 247-250.
MOURA PH, et al. Poluição atmosférica e hospitalizações por agravos pulmonares em idosos em Nova Iguaçu. Estudos Interdisciplinares do Envelhecimento, 2021; 26(1):411-430, 2021.
OUR WORLD IN DATA. Cancer - Our World in Data. 2019. Disponível em: https://ourworldindata.org/cancer. Acessado em: 15 de abril de 2023.
RIBEIRO AG, et al. Influência da densidade de tráfego veicular na internação por câncer do aparelho respiratório no Município de São Paulo, Brasil. Cadernos de Saúde Publica, 2019; 35(1): e00128518.
ROY PS e SAIKIA BJ. Cancer and cure: A critical analysis. Indian Journal Cancer, 2016; 53(3):441-442.
SANTOS HLC, et al. Mortalidade por Neoplasias no Estado da Bahia de 2008 a 2018. Revista Brasileira de Cancerologia, 2022; 68(1): e-081376.
SILVA ET e SOUZA TFMP. Incidência de carcinomas mamários no sexo masculino: uma revisão da literatura. Research, Society and Development, 2022; 11(15): e163111537126.
SOUZA LG e SIVIERO PCL. Diferenciais por sexo na mortalidade evitável e ganhos potenciais de esperança de vida em São Paulo, SP: um estudo transversal entre 2014 e 2016. Epidemiologia e Serviços de Saúde, 2020; 29(3):e2018451.
SOUZA MM, et al. Taxa de mortalidade por neoplasia maligna de mama em mulheres residentes da região Carbonífera Catarinense no período de 1980 a 2009. Caderno de Saúde Coletiva 2013; 21 (4): 384-90.
TURNER MC, et al. Ambient Air Pollution and Cancer Mortality in the Cancer Prevention Study II. Environmental Health Perspectives, 2017; 125(8):087013.
WORLD HEALTH ORGANIZATION. Air Pollution and Cancer: Outdoor air pollution a leading environmental cause of cancer deaths. 2013. Disponível em: http://www.iarc.fr/en/publications/books/sp161/index.php. Acessado em: 15 de abril de 2023.
ZENG C, et al. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncology, 2015; (1):88-96.